Trident Texofab Ltd. | Small-cap | Consumer Cyclical
₹345.00
1.91%
| Trident Texofab Stock Comparison:
Trident Texofab vs KPR MillTrident Texofab vs TridentTrident Texofab vs Sanathan TextilesTrident Texofab vs RaymondTrident Texofab vs Bombay DyeingTrident Texofab vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 280.8M
Gross Profit 44.1M 15.72%
Operating Income 16.6M 5.90%
Net Income 10.2M 3.62%
EPS (Diluted) ₹0.69

Balance Sheet Metrics

Total Assets 1.0B
Total Liabilities 533.4M
Shareholders Equity 472.4M
Debt to Equity 1.13

Cash Flow Metrics

Revenue & Profitability Trend

Trident Texofab Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i1.2B994.8M963.6M842.9M499.3M
Cost of Goods Sold i1.1B850.5M815.8M726.5M424.6M
Gross Profit i144.4M144.3M147.8M116.5M74.6M
Gross Margin % i11.8%14.5%15.3%13.8%14.9%
Operating Expenses
Research & Development i4.0K27.0K38.0K35.0K21.0K
Selling, General & Administrative i3.3M5.2M5.2M4.5M4.2M
Other Operating Expenses i38.6M33.0M32.5M27.2M21.0M
Total Operating Expenses i41.9M38.2M37.7M31.7M25.2M
Operating Income i57.2M62.5M65.7M45.5M18.6M
Operating Margin % i4.7%6.3%6.8%5.4%3.7%
Non-Operating Items
Interest Income i8.7M2.4M17.0M3.1M15.5M
Interest Expense i62.9M57.3M55.6M40.0M27.9M
Other Non-Operating Income-----
Pre-tax Income i25.8M11.7M27.3M12.7M9.0M
Income Tax i656.0K889.0K5.1M2.9M5.5M
Effective Tax Rate % i2.5%7.6%18.6%22.8%60.9%
Net Income i25.1M10.8M22.2M9.8M3.5M
Net Margin % i2.1%1.1%2.3%1.2%0.7%
Key Metrics
EBITDA i82.3M82.3M100.7M67.0M46.7M
EPS (Basic) i₹2.44₹1.07₹2.20₹0.98₹0.35
EPS (Diluted) i₹2.15₹1.07₹2.20₹0.98₹0.35
Basic Shares Outstanding i102890001007010010070100100700009991000
Diluted Shares Outstanding i102890001007010010070100100700009991000

Income Statement Trend

Trident Texofab Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i1.1M1.1M616.0K225.0K161.0K
Short-term Investments i30.5M475.0K-163.0K183.0K
Accounts Receivable i407.1M366.7M338.7M308.5M302.8M
Inventory i159.6M135.5M106.4M72.7M80.1M
Other Current Assets-3.0K-2.0K-1.0K-1.0K15.8M
Total Current Assets i737.4M521.0M466.9M400.3M400.0M
Non-Current Assets
Property, Plant & Equipment i31.1M32.4M33.2M34.1M142.1M
Goodwill i-----
Intangible Assets i-----
Long-term Investments-----
Other Non-Current Assets14.2M14.3M12.2M12.2M11.6M
Total Non-Current Assets i268.3M297.9M306.2M309.6M277.8M
Total Assets i1.0B819.0M773.1M709.9M677.7M
Liabilities
Current Liabilities
Accounts Payable i148.6M166.9M176.2M113.9M162.2M
Short-term Debt i193.3M194.9M163.1M157.2M118.6M
Current Portion of Long-term Debt-----
Other Current Liabilities-2.0K6.5M-1.0K3.0K1.6M
Total Current Liabilities i407.5M422.8M372.3M302.5M302.3M
Non-Current Liabilities
Long-term Debt i102.7M206.2M217.5M249.2M221.6M
Deferred Tax Liabilities i5.4M11.1M13.8M9.7M6.8M
Other Non-Current Liabilities-3.0K16.3M1.7K36.5M27.2M
Total Non-Current Liabilities i125.9M233.6M249.0M277.8M255.6M
Total Liabilities i533.4M656.4M621.3M580.3M558.0M
Equity
Common Stock i135.6M100.7M100.7M100.7M100.7M
Retained Earnings i77.1M52.6M41.8M19.6M9.8M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i472.4M162.6M151.8M129.6M119.8M
Key Metrics
Total Debt i296.0M401.2M380.6M406.3M340.2M
Working Capital i329.9M98.2M94.5M97.8M97.6M

Balance Sheet Composition

Trident Texofab Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i25.8M11.7M27.3M12.7M9.0M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-173.9M-53.2M-71.9M-2.1M-18.7M
Operating Cash Flow i-106.0M-3.7M-10.7M33.4M14.9M
Investing Activities
Capital Expenditures i0-575.0K-2.2M-41.6M-99.2M
Acquisitions i-----
Investment Purchases i----12.3M-856.0K
Investment Sales i48.3M006.5M0
Investing Cash Flow i43.3M-7.0M2.6M-56.7M-103.3M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i--015.8M108.9M
Debt Repayment i-104.8M-11.3M-31.6M--
Financing Cash Flow i410.6M19.7M-25.7M55.0M111.8M
Free Cash Flow i-137.2M26.6M56.4M-27.6M-79.6M
Net Change in Cash i347.8M9.0M-33.8M31.7M23.4M

Cash Flow Trend

Trident Texofab Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 158.94
Price to Book 7.32
Price to Sales 4.08
PEG Ratio 36.56

Profitability Ratios

Profit Margin 2.28%
Operating Margin 5.90%
Return on Equity 5.31%
Return on Assets 2.50%

Financial Health

Current Ratio 1.81
Debt to Equity 62.67
Beta -1.24

Per Share Data

EPS (TTM) ₹2.13
Book Value per Share ₹46.27
Revenue per Share ₹107.69

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
ttfl5.1B158.947.325.31%2.28%62.67
KPR Mill 364.5B44.457.3216.30%12.60%9.32
Trident 148.4B33.663.308.00%6.27%35.39
Sanathan Textiles 42.7B28.012.348.87%5.09%59.97
Raymond 41.4B90.931.05183.56%271.84%17.81
Bombay Dyeing 36.7B7.511.5520.91%31.88%0.13

Financial data is updated regularly. All figures are in the company's reporting currency.